{"id":"NCT01079234","sponsor":"Novo Nordisk A/S","briefTitle":"Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes","officialTitle":"A 26-week Trial Investigating the Dosing Flexibility, Efficacy and Safety of NN1250 in Subjects With Type 1 Diabetes With a 26-week Extension (Beginâ„¢: Flex T1)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-03","primaryCompletion":"2010-11","completion":"2011-05","firstPosted":"2010-03-03","resultsPosted":"2015-12-31","lastUpdate":"2017-02-09"},"enrollment":493,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 1"],"interventions":[{"type":"DRUG","name":"insulin degludec","otherNames":[]},{"type":"DRUG","name":"insulin glargine","otherNames":[]},{"type":"DRUG","name":"insulin aspart","otherNames":[]}],"arms":[{"label":"Flex + insulin aspart","type":"EXPERIMENTAL"},{"label":"Fixed + insulin aspart","type":"EXPERIMENTAL"},{"label":"IGlar + insulin aspart","type":"ACTIVE_COMPARATOR"}],"summary":"This trial is conducted in Europe and in the United States of America (USA). The aim of this trial is to investigate the efficacy and safety of NN1250 (insulin degludec) in subjects with type 1 diabetes.","primaryOutcome":{"measure":"Main Trial (Primary Endpoint): Change in Glycosylated Haemoglobin (HbA1c) After 26 Weeks of Treatment","timeFrame":"Week 0, Week 26","effectByArm":[{"arm":"IDeg OD FF","deltaMin":-0.4,"sd":0.59},{"arm":"IDeg OD","deltaMin":-0.41,"sd":0.71},{"arm":"IGlar OD","deltaMin":-0.58,"sd":0.72}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":5},"locations":{"siteCount":82,"countries":["United States","Belgium","Germany","Greece","Norway","Poland","United Kingdom"]},"refs":{"pmids":["23130654","26484727","24170235","26121451","26232910","26663320","23393185"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":25,"n":329},"commonTop":["Nasopharyngitis","Headache","Upper respiratory tract infection","Oropharyngeal pain","Hypoglycaemia"]}}